MSAM
CRSP icon

Moloney Securities Asset Management’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-13,161
Closed -$235K 277
2017
Q3
$235K Buy
+13,161
New +$235K 0.1% 222